Author:
Nakamura Toshifumi,Hayashi Kaori
Publisher
Springer Science and Business Media LLC
Reference10 articles.
1. Vaidya A, Hundemer GL, Nanba K, Parksook WW, Brown JM. Primary aldosteronism: state-of-the-art review. Am J Hypertens. 2022;35:967–88.
2. Yang MH, Tyan YS, Huang YH, Wang SC, Chen SL. Comparison of radiofrequency ablation versus laparoscopic adrenalectomy for benign aldosterone-producing adenoma. Radio Med. 2016;121:811–9.
3. Inoue H, Nakajo M, Miyazono N, Hori A, Kanetsuki I, Hokotate H, et al. Successful therapeutic embolization of aldosteronoma using absolute ethanol. Radiat Med. 1993;11:256–9.
4. Zhang H, Li Q, Liu X, Zhao Z, He H, Sun F, et al. Adrenal artery ablation for primary aldosteronism without apparent aldosteronoma: an efficacy and safety, proof-of-principle trial. J Clin Hypertens. 2020;22:1618–26.
5. Dong H, Zou Y, He J, Deng Y, Chen Y, Song L, et al. Superselective adrenal arterial embolization for idiopathic hyperaldosteronism: 12-month results from a proof-of-principle trial. Catheter Cardiovasc Inter. 2021;97:976–81.